CDMO News

• PanTera signs agreement with Bayer for actinium-225 supply from Mol, Belgium location
• Novo Nordisk's investment in expansion of manufacturing facilities in Kalundborg, Denmark exceeds 5.6 billion Euro.
• Lonza Stein (CH) Introduces New Filling Line for Commercial Supply of Antibody-Drug Conjugates to Exclusive Customer
• Novo Nordisk to invest €2.1bn in expanding manufacturing facilities in Hillerød, Denmark
• WACKER strengthens its biotechnology business with the acquisition of ADL Biopharma in Leon, Spain
• Lonza Finishes Manufacturing Line for Clinical and Commercial Drug Products in Visp (CH)
• Sandoz to Construct New Biologics Production Plant in Lendava, Slovenia, to Meet Growing Global Demand for Biosimilar Medicines
• Expansion of Conjugation Facility in Visp, Switzerland Successfully Completed by Lonza
• Lonza Plans to Build a Large-Scale, Commercial Drug Product Fill & Finish Facility in Stein (CH)
• Arxada Plans CHF 20m Investment in Industrial Biotechnology Plant in Kouřim, Czech Republic
• Eurofins Increases Chemistry Capacity to Meet Growing Customer Demand in Drug Discovery Market
• Investment by WACKER in Amsterdam Biotech Site
• Expansion of AGC's Spanish Synthetic Pharmaceutical Production Base
• Investment in Multi-Purpose Plant for Allessa by WeylChem Group
• WuXi Vaccines Plans $240 Million Manufacturing Facility in Ireland
• Major Investments in Dessau BioPharmaPark by Merz and Oncotec
• Expansion of Manufacturing Capacity for Biotech Medicines Receives Investment from Merck
• Cerbios expands its manufacturing capacity for high potency APIs through additional investments
• Continuous Technology Drives Almac Group's Progress
• Investment by WACKER in Jena Biotech Site, Germany
• AGC Biologics Increases Capacity at Facility in Copenhagen, Denmark
• Centerpiece for global launches: Ingelheim's new tablet production facility
• Boehringer Ingelheim plans to invest 65 million euros in avian vaccines.
• Saltigo marks 50 years of groundbreaking chemistry
• Expansion of production site in Portugal by Fresenius Kabi
• Takeda Completes New Manufacturing Facilities at Oranienburg Site in Germany
• Construction to Begin on GCP2 Production Facility at Takeda Ireland Limited Site in Grange Castle
• Investment in New Capacity and Continuous Flow Technology at Cambrex's Karlskoga, Sweden Facility
• Takeda plans €40m investment in new production facility at Grange Castle site in Dublin